Paul F. Truex

Chief Executive Officer, Anthera Pharmaceuticals.

Companies

Milestone Pharmaceuticals Inc.Board member May 8, 2019 to Jun 1, 2022¹
CymaBay Therapeutics (United States)Board member Apr 1, 2016 to Jan 28, 2021²
Anthera PharmaceuticalsBoard member Feb 23, 2010 to Jan 9, 2018³
Anthera PharmaceuticalsExecutive Chaiman May 19, 2017 to May 19, 2017⁴
Anthera PharmaceuticalsChair Dec 6, 2016 to Dec 6, 2016⁵
Anthera PharmaceuticalsChief executive officer Feb 23, 2010 to Sep 22, 2016³
Anthera PharmaceuticalsPresident Feb 23, 2010 to Sep 18, 2015³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 31, 2022Bought 5,000 shares at $5.60 of Milestone Pharmaceuticals Inc.⁶
May 31, 2022Exercised options 822 shares at $2.66 of Milestone Pharmaceuticals Inc.⁶
May 31, 2022Exercised options 22,870 shares at $1.54 of Milestone Pharmaceuticals Inc.⁶
May 31, 2022Exercised options 45,072 shares at $1.54 of Milestone Pharmaceuticals Inc.⁶
May 31, 2022Exercised options 8,016 shares at $1.12 of Milestone Pharmaceuticals Inc.⁶

The numbers on this page point here. Each one links to the record it came from.